
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
Paul Buckman (Director, Division of Online Communications, CDER, FDA) explains the impetus for FDA’s mobile apps and announces FDA’s newest mobile app,






